Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-24 @ 2:53 PM
NCT ID:
NCT06059859
Eligibility Criteria:
Inclusion Criteria:
Untreated, biopsy-proven adenocarcinoma of the prostate Age ≥18 years
European Association of Urology (EAU) low or intermediate risk prostate cancer:
* PSA≤20 ng/ml
* cT≤2b
* International Society for Urological Pathology \[ISUP\] grade group≤III Written informed consent provided for participation in the trial International Index of Erectile Function-5 (IIEF-5)≥20 No contraindications for multiparametric magnetic resonance imaging (mpMRI)
Exclusion Criteria:
Any prior therapy for prostate cancer
European Association of Urology (EAU) high risk prostate cancer:
* PSA\>20 ng/ml or
* cT\>2b or
* ISUP grade group\>III International Index of Erectile Function-5 (IIEF-5)\<20 Prostate cancer with sarcomatoid or spindle cell or neuroendocrine small cell components Morbidity that would limit compliance with study protocols Controindications to perform mpMRI
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT06059859
Study Brief:
Protocol Section:
NCT06059859